InvestmentJul 30, 2026, 08:32 AM
NewGenIvf's K25.ai Stake Valued at $26M, Unrealized Gain $8.5M
AI Summary
NewGenIvf Group Ltd provided an update on its strategic investment in K25.ai, announcing that its 13% stake is now valued at approximately US$26 million. This valuation, based on K25.ai's US$200 million implied valuation from its Series A round, represents an expected unrealized gain of about US$8.5 million, significantly strengthening NewGenIvf's balance sheet. The company also expects its total outstanding Class A ordinary shares to reach approximately 5.9 million following a recently announced issuance.
Key Highlights
- NewGenIvf's 13% stake in K25.ai is now valued at approximately US$26 million.
- The K25.ai investment represents an expected unrealized gain of about US$8.5 million.
- K25.ai's implied valuation is US$200 million following its recently closed Series A investment round.
- NewGenIvf's total outstanding Class A ordinary shares are expected to reach 5.9 million.
- The company reported a net profit of US$9.9 million for the fiscal year ended December 31, 2025.
- Net assets were approximately US$25.98 million as of December 31, 2025.
Price Impact
More from NIVF